SecBot SecBot
8-K ·Filed May 14, 2026

PROF

Profound Medical Corp.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001171843-26-003441
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

Monitor AUA meeting presentations on May 16 for any clinical data readouts that could influence adoption sentiment. The PSMA PET integration initiative is exploratory with no timeline, no near-term revenue impact expected.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$6.97
T+0 close · May 14, 2026 · via day close
Latest settled
+0.14%
T+60 · $6.98
Vs SPY
−4.37%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 15 $6.97entry
  2. T+1 · 6mo ago −1.15%α −1.09% · $6.89
  3. T+5 · 6mo ago −2.01%α −2.97% · $6.83
  4. T+20 · 5mo ago −3.73%α −5.85% · $6.71
  5. T+60 · 3mo ago +0.14%α −4.37% · $6.98

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Profound Medical issued a press release announcing that its TULSA Procedure will be featured in four oral presentations at the AUA Annual Meeting on May 16, 2026, and that it is launching an initiative to explore integrating PSMA PET molecular imaging with TULSA-PRO for ablation planning. This is a routine conference-related disclosure with no financial data or material operational changes.

Key Facts

  • TULSA Procedure to be highlighted in four oral presentations at AUA Annual Meeting on May 16, 2026
  • Profound launching initiative to explore integration of PSMA PET molecular imaging with TULSA-PRO treatment planning software
  • No financial results, guidance, or material agreements disclosed

Financial Impact

No financial figures disclosed in the filing

Risk Factors

  • PSMA PET integration initiative is exploratory with no guaranteed commercial availability
  • TULSA-PRO compatibility with 0.55T MRI (Siemens Free.Max) not commercially available in all markets, including the US

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
80% bullish (5 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001171843-26-003441
Exhibit: exh_991.htm0001171843-26-003441
Document: 0001171843-26-003441-index-headers.html0001171843-26-003441
Document: 0001171843-26-003441-index.html0001171843-26-003441
Document: 0001171843-26-003441.txt0001171843-26-003441

US Market Status

Market Closed · Opens Wed (9h 59m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 14, 2026